Moderna explicitly states that the decline in customer demand for its COVID vaccine continued into 2025 as the market shifts to a 'more competitive and commercially driven environment'. This pressure to offset revenue decline from its flagship product makes the company more receptive to solutions that can accelerate new product launches or improve commercial effectiveness.
Filing excerpt
For example, we experienced a decline in customer demand for our COVID vaccine in 2023 and 2024, and this trend continued in 2025 as the market transitions to a more competitive and commercially driven environment, with broader external factors continuing to affect market dynamics.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qmarketShareLossGet every 10-Q signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/6c61caba-d333-4425-b5ba-500e94891866 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "6c61caba-d333-4425-b5ba-500e94891866",
"signal_type": "sec-10q",
"signal_subtype": "marketShareLoss",
"detected_at": "2026-08-04T07:04:24.504+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "Moderna explicitly states that the decline in customer demand for its COVID vaccine continued into 2025 as the market shifts to a 'more competitive and commercially driven environment'. This pressure to offset revenue decline from its flagship product makes the company more receptive to solutions that can accelerate new product launches or improve commercial effectiveness.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Company cites continued decline in COVID vaccine demand amid rising competition.",
"excerpts": "For example, we experienced a decline in customer demand for our COVID vaccine in 2023 and 2024, and this trend continued in 2025 as the market transitions to a more competitive and commercially driven environment, with broader external factors continuing to affect market dynamics.",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/mrna-20260630.htm",
"filing_date": "2026-07-31",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Urgency to improve",
"signal_category": "market"
}
}
curl https://signals.autobound.ai/v1/signals/6c61caba-d333-4425-b5ba-500e94891866 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.